Protocol for an Observational Study on the Correlation Between Dosha Kshaya-Vriddhi and Taste Preferences (Shad-Rasa) as Preventive Measures in Ayurveda

Abstract

Introduction:

The balance of dosha in the human body is central to Ayurveda, influencing an individual's health and well-being. Dosha imbalances, particularly Kshaya (reduction) and Vriddhi (increase), can significantly affect physiological functions. One of the key manifestations of dosha imbalance is the individual's preference or aversion towards the six tastes (Shad-Rasa). This study aims to explore the correlation between dosha imbalances and these preferences, and investigate how this relationship can serve as a preventive measure in Ayurveda treatment protocols.

Methods:

This observational cross-sectional study will be conducted on a sample of individuals diagnosed with varying dosha imbalances (Kshaya and Vriddhi). Participants will undergo a detailed assessment through a structured questionnaire to assess their aversion and liking towards the six tastes. Dosha imbalances will be determined based on clinical examination, history, and standardized Ayurveda diagnostic criteria. Statistical analysis will be used to explore the correlation between dosha imbalances and taste preferences.

Results:

The study is expected to reveal a significant correlation between specific dosha imbalances (Kshaya and Vriddhi) and aversion or liking toward particular tastes. A detailed analysis will highlight the patterns of preferences in individuals with dominant dosha imbalances, offering insights into the physiological link between dosha status and taste sensitivity.

Discussion:

The findings of this study could have practical implications in Ayurveda preventive and therapeutic practices. Understanding the correlation between dosha imbalances and taste preferences could allow practitioners to tailor dietary recommendations more effectively, providing an individualized approach to maintaining dosha balance. This could enhance the preventative aspects of Ayurveda treatments, improving patient outcomes by addressing imbalances before they manifest as disease.

IEC Letter No. - SKAU/Acad/2024/11533